These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 9764959)

  • 1. Midazolam pharmacokinetics following intravenous and buccal administration.
    Schwagmeier R; Alincic S; Striebel HW
    Br J Clin Pharmacol; 1998 Sep; 46(3):203-6. PubMed ID: 9764959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of midazolam administered as a concentrated intranasal spray. A study in healthy volunteers.
    Knoester PD; Jonker DM; Van Der Hoeven RT; Vermeij TA; Edelbroek PM; Brekelmans GJ; de Haan GJ
    Br J Clin Pharmacol; 2002 May; 53(5):501-7. PubMed ID: 11994056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A pharmacokinetic and pharmacodynamic study, in healthy volunteers, of a rapidly absorbed intranasal midazolam formulation.
    Wermeling DP; Record KA; Archer SM; Rudy AC
    Epilepsy Res; 2009 Feb; 83(2-3):124-32. PubMed ID: 19046855
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of semisimultaneous midazolam administration for hepatic and intestinal cytochrome P450 3A phenotyping.
    Lee JI; Chaves-Gnecco D; Amico JA; Kroboth PD; Wilson JW; Frye RF
    Clin Pharmacol Ther; 2002 Dec; 72(6):718-28. PubMed ID: 12496753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of midazolam after intranasal administration.
    Burstein AH; Modica R; Hatton M; Forrest A; Gengo FM
    J Clin Pharmacol; 1997 Aug; 37(8):711-8. PubMed ID: 9378843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and pharmacodynamics of midazolam after intravenous and intramuscular administration in alpacas.
    Aarnes TK; Fry PR; Hubbell JA; Bednarski RM; Lerche P; Chen W; Bei D; Liu Z; Lakritz J
    Am J Vet Res; 2013 Feb; 74(2):294-9. PubMed ID: 23363357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic evaluation of novel midazolam gel formulations following buccal administration to healthy dogs.
    Aldawsari MF; Lau VW; Babu RJ; Arnold RD; Platt SR
    Am J Vet Res; 2018 Jan; 79(1):73-82. PubMed ID: 29287157
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of oral posaconazole on the pharmacokinetic properties of oral and intravenous midazolam: a phase I, randomized, open-label, crossover study in healthy volunteers.
    Krishna G; Moton A; Ma L; Savant I; Martinho M; Seiberling M; McLeod J
    Clin Ther; 2009 Feb; 31(2):286-98. PubMed ID: 19302901
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of multiple-dose, oral rifaximin on the pharmacokinetics of intravenous and oral midazolam in healthy volunteers.
    Pentikis HS; Connolly M; Trapnell CB; Forbes WP; Bettenhausen DK
    Pharmacotherapy; 2007 Oct; 27(10):1361-9. PubMed ID: 17896891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microdosed midazolam for the determination of cytochrome P450 3A activity: Development and clinical evaluation of a buccal film.
    Kiene K; Hayasi N; Burhenne J; Uchitomi R; Sünderhauf C; Schmid Y; Haschke M; Haefeli WE; Krähenbühl S; Mikus G; Inada H; Huwyler J
    Eur J Pharm Sci; 2019 Jul; 135():77-82. PubMed ID: 31102650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetic studies of intramuscular midazolam in guinea pigs challenged with soman.
    Capacio BR; Byers CE; Merk KA; Smith JR; McDonough JH
    Drug Chem Toxicol; 2004 May; 27(2):95-110. PubMed ID: 15198070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of age and gender on intravenous midazolam premedication: a randomized double-blind study.
    Sun GC; Hsu MC; Chia YY; Chen PY; Shaw FZ
    Br J Anaesth; 2008 Nov; 101(5):632-9. PubMed ID: 18772216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of oral clotrimazole troches on the pharmacokinetics of oral and intravenous midazolam.
    Shord SS; Chan LN; Camp JR; Vasquez EM; Jeong HY; Molokie RE; Baum CL; Xie H
    Br J Clin Pharmacol; 2010 Feb; 69(2):160-6. PubMed ID: 20233179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of saquinavir on the pharmacokinetics and pharmacodynamics of oral and intravenous midazolam.
    Palkama VJ; Ahonen J; Neuvonen PJ; Olkkola KT
    Clin Pharmacol Ther; 1999 Jul; 66(1):33-9. PubMed ID: 10430107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of midazolam after intravenous administration to horses.
    Hubbell JA; Kelly EM; Aarnes TK; Bednarski RM; Lerche P; Liu Z; Lakritz J
    Equine Vet J; 2013 Nov; 45(6):721-5. PubMed ID: 23489241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Midazolam plasma concentration after anesthesia premedication in clinical routine - an observational study : Midazolam plasma concentration after anesthesia premedication.
    Steiner C; Steurer MP; Mueller D; Zueger M; Dullenkopf A
    BMC Anesthesiol; 2016 Oct; 16(1):105. PubMed ID: 27776488
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics of midazolam and alpha-hydroxy-midazolam following rectal and intravenous administration.
    Clausen TG; Wolff J; Hansen PB; Larsen F; Rasmussen SN; Dixon JS; Crevoisier C
    Br J Clin Pharmacol; 1988 Apr; 25(4):457-63. PubMed ID: 3382589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics and clinical efficacy of midazolam in children with severe malaria and convulsions.
    Muchohi SN; Kokwaro GO; Ogutu BR; Edwards G; Ward SA; Newton CR
    Br J Clin Pharmacol; 2008 Oct; 66(4):529-38. PubMed ID: 18662297
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flumazenil reduces midazolam-induced cognitive impairment without altering pharmacokinetics.
    Rogers JF; Morrison AL; Nafziger AN; Jones CL; Rocci ML; Bertino JS
    Clin Pharmacol Ther; 2002 Dec; 72(6):711-7. PubMed ID: 12496752
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absolute bioavailability of midazolam after subcutaneous administration to healthy volunteers.
    Pecking M; Montestruc F; Marquet P; Wodey E; Homery MC; Dostert P
    Br J Clin Pharmacol; 2002 Oct; 54(4):357-62. PubMed ID: 12392582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.